Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinazoline analogs as receptor tyrosine kinase inhibitors

Quinazoline analogs as receptor tyrosine kinase inhibitors

US Patent 9676791 · Granted Jun 13, 2017

Estimated economic value: $10,834,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds, compositions and methods2025
Benzoimidazol benzomidazol-1,2-yl amides as Kv7 channel activators2025
Compounds and compositions for the inhibition of NAMPT2025
Antiviral pyrazolopiridinone compounds2025
KV7 channel activators compositions and methods of use2025
5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases2025
Imaging methods using deuterated compounds2025
N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I r2024
N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I r2024
10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1′,2′:4,5]pyrazi2024
Fused bicyclic compounds useful as ubiquitin-specific peptidase 30 inhibitors2024
Purinones as ubiquitin-specific protease 1 inhibitors2024